Key result
VA-ECMO and modified anticoagulation successfully bridge catastrophic antiphospholipid syndrome with cardiogenic shock to transplantation.
Case Report (n=1)
No
Catastrophic antiphospholipid syndrome can present as refractory peripartum cardiogenic shock that may require high-intensity anticoagulation, mechanical circulatory support, and urgent orthotopic heart transplantation.
Supports multidisciplinary management with ECMO and transplantation in refractory peripartum catastrophic APS shock; leaves open generalizability from this single case.
BACKGROUND: Cardiac involvement in antiphospholipid syndrome (APS) can present as valvular disease, ventricular dysfunction, and thrombosis. CASE SUMMARY: A 32-year-old woman with APS and systemic lupus erythematosus presented with cardiogenic shock after a cesarean section delivery for HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Echocardiogram showed biventricular dysfunction, and coronary angiography was negative. Despite medical management, her condition worsened, and she was placed on venoarterial extracorporeal membrane oxygenation (ECMO). Extensive thrombosis formed at the vascular catheters and ECMO inflow cannula. DISCUSSION: Our patient developed refractory shock with arterial and venous thrombosis concerning for catastrophic APS. She was treated with plasmapheresis, steroids, and anticoagulation with a modified higher intensity protocol. She underwent orthotropic heart transplantation 10 days after hospitalization. Biopsy of the explanted heart revealed myocardium with extensive transmural necrosis and granulation tissue. TAKE-HOME MESSAGES: APS-associated cardiomyopathy confers a poor prognosis. Management requires a multidisciplinary approach that includes hematologic interventions and advanced therapies with mechanical circulatory support.
No takes yet. Share an insight, caveat, or question.
Naimi et al. (2026) conducted a case report in Cardiogenic shock secondary to catastrophic antiphospholipid syndrome (n=1). Orthotopic heart transplantation, VA-ECMO, and high-intensity anticoagulation was evaluated on Patient survival and clinical recovery. The patient with catastrophic antiphospholipid syndrome and refractory cardiogenic shock was successfully managed with ECMO, modified intense anticoagulation, and orthotopic heart transplantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: